Jeanine Roeters van Lennep has been working as internist specialized in vascular medicine at the Erasmus Medical Center, Rotterdam, the Netherlands since 2010.
She is head of the vascular medicine clinic specialized in hereditary dyslipidemia. She combines this research interest with gender-specific medicine.

Her scientific research is dedicated to cardiovascular prevention, specifically diagnosis and treatment of Familial Hypercholesterolemia and sex-specific cardiovascular risk factors such as pre-eclampsia for which she obtained grants of e.g. the Dutch Heart Foundation and the Dutch Research Council.

She is very eager to share her enthusiasm on sex- and gender-specific medicine by organizing educational activities such as the 3-day Gender&Health Course and mentoring junior doctors and researchers.
Jeanine has broad leadership experience as board member of various scientific societies. Currently she is chair of the Dutch Society of Vascular Medicine, chair of the HORIZONSCAN committee of the Dutch National Healthcare Institute to review upcoming cardiovascular drugs, and board member of the Dutch Society of Gender&Health. Moreover she has been chair of the first Dutch Guideline on Dyslipidemia.
She is also involved in the Scandinavian Society of Atherosclerosis Research, an official EAS National Society, for which she organized invited speakers as chairperson in several editions and currently holds the post as financial auditor.
Jeanine is an active member of the EAS. Besides having attended and actively participated in many EAS congresses in the past years, she also organized the very successful Pediatric Familial Hypercholesterolemia Symposium as an official satellite symposium of the 87th EAS congress in 2019.

Contributions

LCN Consensus Statement on SMD Webinar – UzbekistanWebinars on-demandLCN WebinarsLipid Clinic NetworkLCN Consensus Statement on SMD Webinar – IraqLCN WebinarsWebinars on-demandLipid Clinic NetworkLCN 2025 Guidelines Update Webinar - LithuaniaLCN WebinarsWebinars on-demandLipid Clinic NetworkLCN 2025 Guidelines Update Webinar – EgyptWebinars on-demandLCN WebinarsLipid Clinic NetworkWebinar on Homozygous Familial Hypercholesterolemia Management (2/3) - FH in women - Part 1/2Rare Disease DayHoFH Awareness DayWebinars on-demand2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias: What's new and what do the experts say?EAS/ESC Guidelines: Combination therapies - guideline updates and clinical caseWebinars on-demand2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemiasPublicationGuidelineClinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statementPublicationConsensus paperThe essential role of sex and gender in atherosclerosis research: A statement from the Editorial Board of Atherosclerosis and Executive Committee of the European Atherosclerosis SocietyCommentariesPublicationRLD 2024 Greece - 10 - DysbetalipoproteinemiaEAS RLD 2024 AthensRLD 2024 Greece - 11 - Q&A - DysbetalipoproteinemiaEAS RLD 2024 AthensWomen and Risk Factors for ASCVD: Sex Specific Considerations92nd EAS Congress 2024ASPC-EAS joint sessionWomen and cardiovascular diseaseWebinars on-demandPaediatric Lipid Working GroupHow to diagnose and treat patients with FHLipid Clinic NetworkImportance of Measuring Lp(a) in patients with HeFH & HoFHLp(a) Awareness DayRare Disease DayHoFH Awareness DayWebinars on-demandJoint FH Webinar series 2023: Let’s manage FH togetherWebinar: How to get your message through on social mediaWebinars on-demandWebinar: How to use social media effectivelyWebinars on-demandEAS Advanced Course – Rare Lipid Disorders – Sweden & NorwayWebinars on-demandEnvironment and cardiovascular risk - Discussion and Q&A90th EAS Congress 2022Environment and cardiovascular riskWomen, dyslipidaemia and atherosclerosisWebinars on-demandGender specific risks in women89th EAS Congress 2021